Fundraise

Zus Health lands $33M Series B to connect fragmented patient records

What's the deal? Zus Health, a Boston-based platform for connected healthcare, has raised a $33 million Series B led by Drive CapitalDealroom has a profile for this one. Try Dealroom →. The round pushes the company's total funding above $100 million.

Who's in? New backers Sanofi VenturesDealroom has a profile for this one. Try Dealroom →, HealthX VenturesDealroom has a profile for this one. Try Dealroom →, and Alumni Ventures joined, alongside existing investors Andreessen Horowitz, F-Prime, Maverick Ventures, and JAZZ Venture PartnersDealroom has a profile for this one. Try Dealroom →.

What's the endgame? Founded in 2021, Zus wants to make patient information easier to access and use without each organisation building its own data infrastructure. At its core is a continuously updated patient record — the Zus Aggregated Profile — that pulls fragmented clinical data into one longitudinal view.

Why now? Electronic health records digitised medicine but left information siloed across systems. Clinicians still spend time hunting for records; patients often repeat their history at every appointment. Zus says AI now offers a chance to make that data not just accessible, but usable in clinical workflows.

What's it building? The platform spans three layers: a unified patient record with AI-powered clinical intelligence; nationwide connectivity across EHR networks, pharmacy data, labs, and care event notifications; and workflows that put the information to work. In August, Zus's network supported more than 110 million transactions.

"We've spent decades digitizing healthcare, but the information still doesn't move with the patient," said founder and chief executive officer Jonathan Bush. "We're building a networked medical record that changes that."

What could go wrong? Connectivity is not the same as adoption. The round's significance will hinge on whether Zus can turn its data network into measurable clinical or operational value — something the announcement alone does not prove.

The signal: The round fits a broader rebound in digital-health investment, where US startups raised $7.4 billion in the first half of 2026. But capital is concentrating in a few large deals, and at $33 million Zus is a more modest bet on infrastructure rather than hype.

Read more: markets.financialcontent.com

Image credit: Generated with Gemini

More top stories